Sunrest LifescienceNSE:SUNREST 41 Gross Margin % is 36.43% as of Mar. 2026, which is 13% above its 10-year median of 32.20. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Sunrest Lifescience ranks worse than 54.29% on this metric.
The historical rank and industry rank for Sunrest Lifescience's Gross Margin % or its related term are showing as below:
NSE:SUNREST'
s Gross Margin % Range Over the Past 10 Years
Min: 28.09 Med: 32.2 Max: 39.91
Current: 36.43
During the past 7 years, the highestGross Margin % of Sunrest Lifescience was 39.91%. The lowest was 28.09%. And the median was 32.20%.
NSE:SUNREST's Gross Margin % is ranked worse than 54.29% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs NSE:SUNREST: 36.43
Sunrest Lifescience had a gross margin of 36.43% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Sunrest Lifescience was 6.60% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sunrest Lifescience had a gross margin of 36.43% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sunrest Lifescience Gross Margin % Related Terms
Sunrest Lifescience Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sunrest Lifescience (NSE:SUNREST) has a Gross Margin % of 36.43% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sunrest Lifescience and its competitors. This is 13% above median its historical median of 32.20. Over the past decade, Sunrest Lifescience's Gross Margin % has ranged from 28.09 to 39.91. According to the industry distribution chart, Sunrest Lifescience ranks #342 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 54.3%.
Is Sunrest Lifescience's Gross Margin % too high?
Sunrest Lifescience's current Gross Margin % of 36.43% is 13% above median its 10-year median of 32.20. Over the past 10 years, this metric has ranged from a low of 28.09 to a high of 39.91. The Healthcare Providers & Services industry median Gross Margin % is 40.08. Sunrest Lifescience's value of 36.43% is 9.1% below this industry median. Based on the distribution chart, Sunrest Lifescience ranks #342 out of 630 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #342 out of 630 companies for Gross Margin %. This places Sunrest Lifescience in the lower half of its industry. The industry median Gross Margin % is 40.08. Sunrest Lifescience's value of 36.43% is 9.1% below this benchmark. Historically, Sunrest Lifescience's own Gross Margin % has ranged from 28.09 to 39.91 over the past decade. While the company's 10-year median is 32.20 vs. the industry median of 40.08, Sunrest Lifescience has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current Gross Margin % of 36.43% is 9.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current Gross Margin % is 36.43%, which is 13% above median its own 10-year median of 32.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Gross Margin % of 36.43%. The current Gross Margin % is 36.43%, which is 13% above median its 10-year median of 32.20 and 9.1% below the Healthcare Providers & Services industry median of 40.08. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Gross Margin % is 36.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score
Get the complete analysis for NSE:SUNREST
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
